前往主要內容區間
  • 李杰醫師相片

    李杰

    放射腫瘤科 :
    台北門診掛號  淡水門診掛號

    李杰醫師本頁二維碼
  • 現職

      • 馬偕醫院放射腫瘤科資深主治醫師
      • 馬偕醫學院醫學系專任副教授

    主要學歷

      • 陽明交通大學生物醫學影像暨放射科學研究所博士 (PhD)
      • 中山醫學大學醫學系 (MD)

    主要經歷

      • 教育部部定副教授
      • 放射腫瘤科專科醫師
      • 中華民國癌症醫學會年輕研究者癌症研究傑出論文獎
      • 財團法人癌症防治基金會放射腫瘤治療學術論文獎
      • 歐洲放射腫瘤學會(ESTRO)會員
      • 美國放射腫瘤學會(ASTRO)會員

主治項目或專長


  • 婦科腫瘤、頭頸癌、泌尿道腫瘤及其他腫瘤之放射治療


論文研究

  1. Jie Lee*, Jhen-Bin Lin. Body Composition During Androgen Deprivation Therapy in Prostate Cancer: A Target to Reduce Cardiovascular Risk. JACC: CardioOncology 2024 Oct, 6 (5) 772–774
  2. Jie Lee*, Jhen-Bin Lin, Wan-Chun Lin, Ya-Ting Jan, Yi-Shing Leu, Yu-Jen Chen, Kun-Pin Wu*. Identifying threshold of CT-defined muscle loss after radiotherapy for survival in oral cavity cancer using machine learning. European Radiology 2025 (DOI: 10.1007/s00330-024-11303-4)
  3. Pin-Chi Chen, Pai-Kai Chiang, Jhen-Bin Lin, Wei-Kung Tsai, Wan-Chun Lin, Ya-Ting Jan, Kun-Pin Wu, Jie Lee*. Thresholds of Body Composition Changes Associated with Survival During Androgen Deprivation Therapy in Prostate Cancer. European Urology Open Science 70 (2024) 99–108.
  4. Lin WC, Weng CS, Ko AT, Jan YT, Lin JB, Wu KP, Lee J*. Interpretable machine learning model based on clinical factors for predicting muscle radiodensity loss after treatment in ovarian cancer. Support Care Cancer. 2024 Jul 24;32(8):544.
  5. Jie Lee*, Jhen-Bin Lin, Chia-Sui Weng, Sue-Jar Chen, Tze-Chien Chen, Yu-Jen Chen. Impact of reduced margin pelvic radiotherapy on gastrointestinal toxicity and outcome in gynecological cancer. Clin Transl Radiat Oncol. 2023 Aug 28:43:100671.
  6. Chia-Sui Weng, Wan-Chun Huang, Chih-Long Chang, Ya-Ting Jan, Tze-Chien Chen, Jie Lee*. Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2114-2125.
  7. Wen-Han Hsu, Ai-Tung Ko, Chia-Sui Weng, Chih-Long Chang, Ya-Ting Jan, Jhen-Bin Lin, Hung-Ju Chien, Wan-Chun Lin, Fang-Ju Sun, Kun-Pin Wu*, Jie Lee*. Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2044-2053.
  8. Jie Lee*, Chia-Sui Weng, Chih-Long Chang et al. Association of prognostic nutritional index with muscle loss and survival in patients with ovarian cancer treated with primary debulking surgery and chemotherapy. Support Care Cancer 2023 Apr 14;31(5):267.
  9. Jie Lee*, Jhen-Bin Lin, Chih-Long Chang et al. Optimal prophylactic para-aortic radiotherapy in locally advanced cervical cancer: anatomy-based versus margin-based delineation. Int J Gynecol Cancer. 2022 May 3;32(5):606-612.
  10. Jie Lee*, Shih-Hua Liu, John Chun-Hao Chen et al. Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study. Radiother Oncol 158 (2021) 83-89.
  11. Jie Lee*, Lin JB, Wu MH et al. Association of bowel radiation dose-volume with skeletal muscle loss during pelvic intensity-modulated radiotherapy in cervical cancer. Support Care Cancer 2021 Sep;29(9):5497-5505.
  12. Jie Lee*, Liu SH, Dai KY, et al. Sarcopenia and systemic inflammation synergistically impact on survival in oral cavity cancer. Laryngoscope 2021. May;131(5):E1530-E1538.
  13. Huang CY, Yang YC, Chen TC, Chen JR, Chen YJ, Wu MH, Jan YT, Chang CL, Jie Lee*. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer. J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):534-546.
  14. Jie Lee*, J.B. Lin, M.H. Wu et al. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer. J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):814-826.
  15. Jie Lee*, C.L. Chang, J.B. Lin et al. Skeletal Muscle Loss is an Imaging Biomarker of Outcome After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Clin Cancer Res. 2018 Oct 15;24(20):5028-5036.
  16. Jie Lee*, CL Chang, JB Lin et al. The effect of body mass index and weight change on late gastrointestinal toxicity in locally advanced cervical cancer treated with intensity-modulated radiotherapy. Int J Gynecol Cancer. 2018 Sep;28(7):1377-1386.
  17. Jie Lee*, J.B. Lin, C.L Chang et al. Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes. Gynecol Oncol. 2018 Feb;148(2):291-298.
  18. Jie Lee, J.B. Lin, C.L Chang et al. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience. Gynecol Oncol. 2017 Jul;146(1):20-26.
  19. Jie Lee, K.L. Hua, S.M. Hsu et al. Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: An optimized organ at risk. Radiother Oncol. 2017 Mar;122(3):423-430.